Table of Contents
Volume 7 | Supplement 3
Publication Date: March 2007- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Introduction | ||
S94 |
Chronic Myeloid Leukemia: Current Management Challenges Tariq Mughal |
|
Contributions | ||
S95-S101 |
Optimal Management of Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia in 2007 Tariq Mughal, John M. Goldman |
|
S102-S104 |
Allogeneic Hematopoietic Progenitor Cell Transplantation for the Treatment of Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors: Lessons Learned to Date Sergio Giralt |
|
S105-S112 |
Emerging Safety Issues with Imatinib and Other Abl Tyrosine Kinase Inhibitors Ehab Atallah, Hagop Kantarjian, Jorge Cortes |
|
S113-S119 |
Novel Abl Kinase Inhibitors in Chronic Myeloid Leukemia in Blastic Phase and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ronan Swords, Yesid Alvarado, Francis Giles |
|
S120-S130 |
Bcr-Abl Kinase Domain Mutations and the Unsettled Problem of Bcr-AblT315I: Looking into the Future of Controlling Drug Resistance in Chronic Myeloid Leukemia Thomas O'Hare, Christopher A. Eide, Michael W. Deininger |
|